1058 Development of AZD9793 for GPC3+ solid tumor treatment: a next generation CD8-guided T cell engager with superior therapeutic index versus conventional formats Article Swipe
Cristina Bergamaschi
,
Upneet K. Sokhi
,
Christine Youn
,
Xiuling Li
,
Cathryn Kelton
,
Eric Y. Chang
,
Andrew C. Yang
,
Alyson Huntley
,
E. Chen
,
Dimitris Karamitros
,
Eric Tu
,
Neil Mody
,
Bharat Burman
,
Sterling Payne
,
Harini Shandilya
,
Hanzhi Zhang
,
Christopher Lloyd
,
Francisca Wollerton
,
Yariv Mazor
,
Frederick W Goldberg
,
Simon J. Dovedi
,
Sašo Čemerski
,
Corinne Cayatte
,
Mark Cobbold
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/jitc-2024-sitc2024.1058
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/jitc-2024-sitc2024.1058
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1136/jitc-2024-sitc2024.1058
- https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdf
- OA Status
- hybrid
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404052730
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404052730Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1136/jitc-2024-sitc2024.1058Digital Object Identifier
- Title
-
1058 Development of AZD9793 for GPC3+ solid tumor treatment: a next generation CD8-guided T cell engager with superior therapeutic index versus conventional formatsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-11-01Full publication date if available
- Authors
-
Cristina Bergamaschi, Upneet K. Sokhi, Christine Youn, Xiuling Li, Cathryn Kelton, Eric Y. Chang, Andrew C. Yang, Alyson Huntley, E. Chen, Dimitris Karamitros, Eric Tu, Neil Mody, Bharat Burman, Sterling Payne, Harini Shandilya, Hanzhi Zhang, Christopher Lloyd, Francisca Wollerton, Yariv Mazor, Frederick W Goldberg, Simon J. Dovedi, Sašo Čemerski, Corinne Cayatte, Mark CobboldList of authors in order
- Landing page
-
https://doi.org/10.1136/jitc-2024-sitc2024.1058Publisher landing page
- PDF URL
-
https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdfDirect OA link when available
- Concepts
-
Computer science, Index (typography), Programming languageTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404052730 |
|---|---|
| doi | https://doi.org/10.1136/jitc-2024-sitc2024.1058 |
| ids.doi | https://doi.org/10.1136/jitc-2024-sitc2024.1058 |
| ids.openalex | https://openalex.org/W4404052730 |
| fwci | 0.53774674 |
| type | article |
| title | 1058 Development of AZD9793 for GPC3+ solid tumor treatment: a next generation CD8-guided T cell engager with superior therapeutic index versus conventional formats |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | A1178 |
| biblio.first_page | A1178 |
| topics[0].id | https://openalex.org/T11491 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | CAR-T cell therapy research |
| topics[1].id | https://openalex.org/T11016 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.991599977016449 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Monoclonal and Polyclonal Antibodies Research |
| topics[2].id | https://openalex.org/T12224 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.968999981880188 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2204 |
| topics[2].subfield.display_name | Biomedical Engineering |
| topics[2].display_name | Nanofabrication and Lithography Techniques |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C41008148 |
| concepts[0].level | 0 |
| concepts[0].score | 0.4369235038757324 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[0].display_name | Computer science |
| concepts[1].id | https://openalex.org/C2777382242 |
| concepts[1].level | 2 |
| concepts[1].score | 0.4236578047275543 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6017816 |
| concepts[1].display_name | Index (typography) |
| concepts[2].id | https://openalex.org/C199360897 |
| concepts[2].level | 1 |
| concepts[2].score | 0.15170246362686157 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q9143 |
| concepts[2].display_name | Programming language |
| keywords[0].id | https://openalex.org/keywords/computer-science |
| keywords[0].score | 0.4369235038757324 |
| keywords[0].display_name | Computer science |
| keywords[1].id | https://openalex.org/keywords/index |
| keywords[1].score | 0.4236578047275543 |
| keywords[1].display_name | Index (typography) |
| keywords[2].id | https://openalex.org/keywords/programming-language |
| keywords[2].score | 0.15170246362686157 |
| keywords[2].display_name | Programming language |
| language | en |
| locations[0].id | doi:10.1136/jitc-2024-sitc2024.1058 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4363604233 |
| locations[0].source.issn | |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Regular and Young Investigator Award Abstracts |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | proceedings-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Regular and Young Investigator Award Abstracts |
| locations[0].landing_page_url | https://doi.org/10.1136/jitc-2024-sitc2024.1058 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5104787966 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Cristina Bergamaschi |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[0].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[0].institutions[0].ror | https://ror.org/043cec594 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | AstraZeneca (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Cristina Bergamaschi |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[1].author.id | https://openalex.org/A5114520753 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Upneet K. Sokhi |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[1].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[1].institutions[0].ror | https://ror.org/043cec594 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | AstraZeneca (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Upneet K Sokhi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[2].author.id | https://openalex.org/A5047231306 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0022-2848 |
| authorships[2].author.display_name | Christine Youn |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[2].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[2].institutions[0].ror | https://ror.org/043cec594 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | AstraZeneca (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Christine Youn |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[3].author.id | https://openalex.org/A5100763045 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1175-2622 |
| authorships[3].author.display_name | Xiuling Li |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[3].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[3].institutions[0].ror | https://ror.org/043cec594 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | AstraZeneca (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Xiuling Li |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[4].author.id | https://openalex.org/A5113356376 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Cathryn Kelton |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[4].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[4].institutions[0].ror | https://ror.org/043cec594 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | AstraZeneca (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Cathryn Kelton |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[5].author.id | https://openalex.org/A5062544014 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3633-5630 |
| authorships[5].author.display_name | Eric Y. Chang |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[5].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[5].institutions[0].ror | https://ror.org/043cec594 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | AstraZeneca (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Eric Chang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[6].author.id | https://openalex.org/A5101532657 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6445-734X |
| authorships[6].author.display_name | Andrew C. Yang |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[6].affiliations[0].raw_affiliation_string | AstraZeneca, Baltimore, MD, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[6].institutions[0].ror | https://ror.org/043cec594 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | AstraZeneca (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Andrew Yang |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | AstraZeneca, Baltimore, MD, USA |
| authorships[7].author.id | https://openalex.org/A5029579355 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9409-7891 |
| authorships[7].author.display_name | Alyson Huntley |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[7].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[7].institutions[0].ror | https://ror.org/043cec594 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | AstraZeneca (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Anna Huntley |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[8].author.id | https://openalex.org/A5112972318 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | E. Chen |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[8].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[8].institutions[0].ror | https://ror.org/043cec594 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | AstraZeneca (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Eddie Chen |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[9].author.id | https://openalex.org/A5114520750 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Dimitris Karamitros |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[9].affiliations[0].raw_affiliation_string | AstraZeneca, New York, NY, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[9].institutions[0].ror | https://ror.org/043cec594 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | AstraZeneca (United States) |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Dimitris Karamitros |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | AstraZeneca, New York, NY, USA |
| authorships[10].author.id | https://openalex.org/A5022849360 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Eric Tu |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[10].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[10].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[10].institutions[0].ror | https://ror.org/043cec594 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | AstraZeneca (United States) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Eric Tu |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[11].author.id | https://openalex.org/A5064802426 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-2260-7658 |
| authorships[11].author.display_name | Neil Mody |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[11].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[11].institutions[0].ror | https://ror.org/043cec594 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | AstraZeneca (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Neil Mody |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[12].author.id | https://openalex.org/A5114520751 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Bharat Burman |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[12].affiliations[0].raw_affiliation_string | AstraZeneca, New York, NY, USA |
| authorships[12].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[12].institutions[0].ror | https://ror.org/043cec594 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | AstraZeneca (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Bharat Burman |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | AstraZeneca, New York, NY, USA |
| authorships[13].author.id | https://openalex.org/A5029229498 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Sterling Payne |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[13].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[13].institutions[0].ror | https://ror.org/043cec594 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | AstraZeneca (United States) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Sterling Payne |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[14].author.id | https://openalex.org/A5000759391 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Harini Shandilya |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[14].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[14].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[14].institutions[0].ror | https://ror.org/043cec594 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | AstraZeneca (United States) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Harini Shandilya |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[15].author.id | https://openalex.org/A5103178965 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-3672-7503 |
| authorships[15].author.display_name | Hanzhi Zhang |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[15].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[15].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[15].institutions[0].ror | https://ror.org/043cec594 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | AstraZeneca (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Hanzhi Zhang |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[16].author.id | https://openalex.org/A5031245283 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-0575-7793 |
| authorships[16].author.display_name | Christopher Lloyd |
| authorships[16].countries | GB |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I105036370 |
| authorships[16].affiliations[0].raw_affiliation_string | AstraZeneca, Cambridge, UK |
| authorships[16].institutions[0].id | https://openalex.org/I105036370 |
| authorships[16].institutions[0].ror | https://ror.org/04r9x1a08 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I105036370 |
| authorships[16].institutions[0].country_code | GB |
| authorships[16].institutions[0].display_name | AstraZeneca (United Kingdom) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Christopher Lloyd |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | AstraZeneca, Cambridge, UK |
| authorships[17].author.id | https://openalex.org/A5114520752 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Francisca Wollerton |
| authorships[17].countries | GB |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I105036370 |
| authorships[17].affiliations[0].raw_affiliation_string | AstraZeneca, Cambridge, UK |
| authorships[17].institutions[0].id | https://openalex.org/I105036370 |
| authorships[17].institutions[0].ror | https://ror.org/04r9x1a08 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I105036370 |
| authorships[17].institutions[0].country_code | GB |
| authorships[17].institutions[0].display_name | AstraZeneca (United Kingdom) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Francisca Wollerton |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | AstraZeneca, Cambridge, UK |
| authorships[18].author.id | https://openalex.org/A5031787481 |
| authorships[18].author.orcid | https://orcid.org/0009-0000-9033-9160 |
| authorships[18].author.display_name | Yariv Mazor |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[18].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[18].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[18].institutions[0].ror | https://ror.org/043cec594 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | AstraZeneca (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Yariv Mazor |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[19].author.id | https://openalex.org/A5114520754 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Frederick W Goldberg |
| authorships[19].countries | GB |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I105036370 |
| authorships[19].affiliations[0].raw_affiliation_string | AstraZeneca, Cambridge, UK |
| authorships[19].institutions[0].id | https://openalex.org/I105036370 |
| authorships[19].institutions[0].ror | https://ror.org/04r9x1a08 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I105036370 |
| authorships[19].institutions[0].country_code | GB |
| authorships[19].institutions[0].display_name | AstraZeneca (United Kingdom) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Frederick W Goldberg |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | AstraZeneca, Cambridge, UK |
| authorships[20].author.id | https://openalex.org/A5073399228 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-0486-1206 |
| authorships[20].author.display_name | Simon J. Dovedi |
| authorships[20].countries | GB |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I105036370 |
| authorships[20].affiliations[0].raw_affiliation_string | AstraZeneca, Cambridge, UK |
| authorships[20].institutions[0].id | https://openalex.org/I105036370 |
| authorships[20].institutions[0].ror | https://ror.org/04r9x1a08 |
| authorships[20].institutions[0].type | company |
| authorships[20].institutions[0].lineage | https://openalex.org/I105036370 |
| authorships[20].institutions[0].country_code | GB |
| authorships[20].institutions[0].display_name | AstraZeneca (United Kingdom) |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Simon Dovedi |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | AstraZeneca, Cambridge, UK |
| authorships[21].author.id | https://openalex.org/A5087503746 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-7240-4600 |
| authorships[21].author.display_name | Sašo Čemerski |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[21].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[21].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[21].institutions[0].ror | https://ror.org/043cec594 |
| authorships[21].institutions[0].type | company |
| authorships[21].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | AstraZeneca (United States) |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Saso Cemerski |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[22].author.id | https://openalex.org/A5067441288 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-0022-4384 |
| authorships[22].author.display_name | Corinne Cayatte |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[22].affiliations[0].raw_affiliation_string | AstraZeneca, Gaithersburg, MD, USA |
| authorships[22].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[22].institutions[0].ror | https://ror.org/043cec594 |
| authorships[22].institutions[0].type | company |
| authorships[22].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | AstraZeneca (United States) |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Corinne Cayatte |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | AstraZeneca, Gaithersburg, MD, USA |
| authorships[23].author.id | https://openalex.org/A5082317251 |
| authorships[23].author.orcid | https://orcid.org/0000-0001-8931-4142 |
| authorships[23].author.display_name | Mark Cobbold |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[23].affiliations[0].raw_affiliation_string | AstraZeneca, Waltham, MA, USA |
| authorships[23].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[23].institutions[0].ror | https://ror.org/043cec594 |
| authorships[23].institutions[0].type | company |
| authorships[23].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | AstraZeneca (United States) |
| authorships[23].author_position | last |
| authorships[23].raw_author_name | Mark Cobbold |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | AstraZeneca, Waltham, MA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 1058 Development of AZD9793 for GPC3+ solid tumor treatment: a next generation CD8-guided T cell engager with superior therapeutic index versus conventional formats |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T11491 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | CAR-T cell therapy research |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W2390279801, https://openalex.org/W4391913857, https://openalex.org/W2358668433, https://openalex.org/W4396701345, https://openalex.org/W2376932109, https://openalex.org/W2001405890, https://openalex.org/W4396696052 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1136/jitc-2024-sitc2024.1058 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4363604233 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Regular and Young Investigator Award Abstracts |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | proceedings-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Regular and Young Investigator Award Abstracts |
| best_oa_location.landing_page_url | https://doi.org/10.1136/jitc-2024-sitc2024.1058 |
| primary_location.id | doi:10.1136/jitc-2024-sitc2024.1058 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4363604233 |
| primary_location.source.issn | |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Regular and Young Investigator Award Abstracts |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://jitc.bmj.com/content/jitc/12/Suppl_2/A1178.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | proceedings-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Regular and Young Investigator Award Abstracts |
| primary_location.landing_page_url | https://doi.org/10.1136/jitc-2024-sitc2024.1058 |
| publication_date | 2024-11-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 24 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.69695957 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |